EDGAR Filing Documents for 0001104659-16-143635

Form 8-K - Current report:

SEC Accession No. 0001104659-16-143635

Filing Date

2016-09-08

Accepted

2016-09-08 10:36:22

Documents

Period of Report

2016-09-06

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a16-18087_18k.htm	8-K	41383
2	EX-2.1	a16-18087_1ex2d1.htm	EX-2.1	525283
3	EX-99.1	a16-18087_1ex99d1.htm	EX-99.1	25429
4	GRAPHIC	g180871mmi001.jpg	GRAPHIC	7141
	Complete submission text file	0001104659-16-143635.txt		603446

Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4

Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118

Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)